Barclays
MED icon

Barclays’s Medifast MED Stock Holding History

Barclays’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,300
Closed -$144K – 5984
2020
Q1 		$144K Sell
2,300
-5,700
-71% -$519K ﹤0.01% 4527
2019
Q4 		$877K Sell
8,000
-10,800
-57% -$1.05M ﹤0.01% 3794
2019
Q3 		$1.95M Buy
18,800
+2,800
+18% +$301K ﹤0.01% 2902
2019
Q2 		$2.05M Buy
16,000
+15,300
+2,186% +$2.13M ﹤0.01% 2878
2019
Q1 		$89K Sell
700
-500
-42% -$63.4K ﹤0.01% 5452
2018
Q4 		$150K Sell
1,200
-10,100
-89% -$1.73M ﹤0.01% 4780
2018
Q3 		$2.5M Buy
11,300
+10,900
+2,725% +$2.21M ﹤0.01% 2616
2018
Q2 		$64K Sell
400
-400
-50% -$51.1K ﹤0.01% 5511
2018
Q1 		$75K Hold
800
– – ﹤0.01% 5594
2017
Q4 		$56K Buy
+800
New +$53.1K ﹤0.01% 5685
2015
Q3 		– Sell
-100
Closed -$3K – 6956
2015
Q2 		$3K Hold
100
– – ﹤0.01% 6685
2015
Q1 		$3K Buy
+100
New +$3.17K ﹤0.01% 6769
2014
Q4 		– Sell
-5,400
Closed -$173K – 7470
2014
Q3 		$173K Buy
+5,400
New +$166K ﹤0.01% 4873
2014
Q2 		– Sell
-500
Closed -$15K – 7715
2014
Q1 		$15K Sell
500
-1,400
-74% -$37.5K ﹤0.01% 6732
2013
Q4 		$49K Sell
1,900
-15,400
-89% -$395K ﹤0.01% 6197
2013
Q3 		$450K Buy
17,300
+11,400
+193% +$305K ﹤0.01% 4228
2013
Q2 		$152K Buy
+5,900
New +$155K ﹤0.01% 5438

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays's MED Position: Q2 2026 in Review

Barclays reduced its Medifast (MED) stake by 57% in Q2 2026, selling an estimated $12.7K and leaving 825 shares worth $8.75K. The position accounts for ﹤0.01% of the portfolio, ranked #4713.

Barclays first reported a position in MED in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.69M in Q1 2021. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Barclays held 825 shares of Medifast worth $8.75K as of Q2 2026.
  • Barclays sold 1,101 Medifast shares in Q2 2026, an estimated $12.7K.
  • Medifast made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4713 holding.
  • Barclays first reported a position in Medifast in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Medifast position peaked at $3.69M in Q1 2021.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.